INTRODUCTION {#sec1-1}
============

Italy is facing an overwhelming epidemic spread of coronavirus disease 2019 (COVID-19). Northern Italy is one of the most affected areas, with exponential growth in cases. Our hospital is almost converted to a COVID-19 hospital. Patients below 18 years represented a minority of COVID-19 cases in the preliminary data from China and Spain.\[[@ref1][@ref2]\] It was, therefore, initially thought that children are relatively immune to COVID-19 infection. This, however, is not correct, and COVID-19 infection is being increasingly reported among children and adolescents. We hereby present our experience with COVID-19 infection in patients below 18 years. We describe peculiarities in clinical presentation and challenges posed in the diagnosis.

SUBJECTS AND METHODS {#sec1-2}
====================

All patients presenting to our hospital between March 30 and April 10, 2020, suspected to have COVID-19 were included. The provisional diagnosis was based on symptoms and history of exposure. Confirmation of COVID status was done using a rapid polymerase chain reaction (PCR) test. All patients underwent at least two rapid PCR tests on a nasopharyngeal swab. Additional samples from other biological fluids, such as cerebrospinal fluid, were also taken in selected cases. Clinical evaluation included physical examination and chest X-ray. Chest computed tomography (CT) was also performed in patients with respiratory distress and/or desaturation.

Cardiac involvement was systematically assessed by serially measured high-sensitivity troponin and transthoracic echocardiography.

RESULTS {#sec1-3}
=======

The first six patients, including three males, presenting to the pediatric emergency were included. The median age was 7 (3--16) years. The clinical presentation was characterized by high fever associated with a combination of gastrointestinal symptoms, sore throat, rash, cough, conjunctivitis, and lymphadenitis \[[Table 1](#T1){ref-type="table"}\]. One female patient presented with neck stiffness and underwent lumbar puncture that turned out to be negative for COIVD-19.

###### 

Summary of clinical presentation and laboratory findings

                               Case 1                                                         Case 2                                                    Case 3                                                                      Case 4                                                          Case 5                                        Case 6                                  Reference range   Median (range)
  ---------------------------- -------------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------------------------- --------------------------------------------------------------- --------------------------------------------- --------------------------------------- ----------------- --------------------
  Gender, age (years)          Male, 7                                                        Female, 3                                                 Male, 9                                                                     Female, 7                                                       Female, 7                                     Male, 16                                                  
  Prodromic symptoms           Fever, gastrointestinal, sore throat, rash, nuchal stiffness   Fever, sore throat, rash, conjunctivitis, lymphadenitis   Fever, gastrointestinal, sore throat, rash, conjunctivitis, lymphadenitis   Fever, gastrointestinal, sore throat, cough, nuchal stiffness   Fever, gastrointestinal, sore throat, cough   Fever, gastrointestinal, rash                             
  Laboratory findings                                                                                                                                                                                                                                                                                                                                                                                       
   Leukocyte (10^9^/L)         32.84                                                          20.74                                                     9.00                                                                        19.04                                                           10.26                                         20.00                                   \<11.00           17.7 (9.0-32.84)
   CRP (mg/L)                  35.3                                                           12.02                                                     257                                                                         48                                                              52.5                                          7.1                                     \<1               41.65 (7.1-257)
   Procalcitonin (ng/mL)       59.8                                                           6.06                                                      0.45                                                                        193.25                                                          7.57                                          NA                                      \<0.05            7.57 (0.45-193.25)
   PLT (10^9^/L)               113                                                            116                                                       672                                                                         145                                                             105                                           250                                     150-400           130.5 (105-672)
   Troponin I-HS (ng/L)        188                                                            112                                                       100                                                                         200                                                             3557                                          1200                                    \<53              194 (100-3557)
   BNP (ng/L)                  952                                                            1519                                                      1800                                                                        2072                                                            444                                           103                                     \<100             1235 (103-2072)
   D-dimer (ng/mL)             NA                                                             NA                                                        7180                                                                        3285                                                            4788                                          4700                                    \<500             4774 (3285-7180)
   Fibrinogen (mg/dL)          NA                                                             NA                                                        640                                                                         924                                                             730                                           370                                     150-450           685 (370-924)
   Ferritin (ng/mL)            1183                                                           893                                                       NA                                                                          1972                                                            3213                                          2027                                    20-250            1972 (893-3213)
   Triglyceride (mg/dL)        538                                                            538                                                       452                                                                         263                                                             NA                                            320                                     40-170            452 (263-538)
  Transaminase                 ++                                                             \+                                                        ++                                                                          ++                                                              ++                                            \+                                                        
  Chest X-ray                  Normal                                                         Mild retrocardiac consolidation                           Mild retrocardiac consolidation                                             Normal                                                          Normal                                        Normal                                                    
  Chest CT                     NA                                                             NA                                                        Interstitial pneumonia                                                      NA                                                              NA                                            NA                                                        
  ECG                          Sinus tachycardia                                              Sinus tachycardia                                         fQRS                                                                        ST elevation                                                    fQRS                                          Sinus tachycardia                                         
  Lowest LVEF (%)              60.0                                                           60.0                                                      45                                                                          25                                                              30.0                                          55                                                        
  Echocardiographic findings   Normal                                                         Coronary involvement                                      Pericardial effusion + coronary involvement                                 Pericardial effusion                                            Pericardial effusion                          Pericardial effusion                                      
  Oxygen therapy               Yes                                                            No                                                        Yes                                                                         Yes                                                             Yes                                           No                                                        
  ICU                          No                                                             No                                                        No                                                                          Yes                                                             Yes                                           Yes                                                       
  Specific therapy             IVIG, antibiotics, ASA, methylprednisolone                     IVIG, antibiotics, ASA, methylprednisolone                IVIG, antibiotics, ASA, methylprednisolone                                  IVIG, antibiotics, hydrocortisone                               IVIG, antibiotics, ASA, methylprednisolone    IVIG, antibiotics, methylprednisolone                     
  Inotropic support            No                                                             No                                                        No                                                                          Yes                                                             Yes                                           Yes                                                       
  COVID-19 swab                Positive                                                       Negative (parents with typical symptoms)                  Negative (parents with typical symptoms)                                    Negative (parents with typical symptoms)                        Positive                                      Positive                                                  
  Clinical diagnosis           Kawasaki                                                       Kawasaki                                                  Kawasaki like, Myocarditis                                                  Myocarditis                                                     Myocarditis                                   Kawasaki                                                  
  LVEF normalization           Yes                                                            Yes                                                       Yes                                                                         Yes                                                             Yes                                           Yes                                                       

CRP: C-reactive protein, PLT: Platelet, BNP: Brain natriuretic peptide, CT: Computed tomography, ECG: Electrocardiogram, LVEF: Left ventricular ejection fraction, ICU: Intensive care unit, NA: Not available, IVIG: Intravenous immunoglobulin, ASA: Acetylsalicylic acid, COVID-19: Coronavirus disease 2019, fQRS: fragmented QRS, +: Two times the upper limit, ++: Three times the upper limit

All patients but one had marked leukocytosis and all had a significant increase of acute-phase reactants and liver enzymes.

[Table 1](#T1){ref-type="table"} summarizes patient laboratory findings.

Three patients had two negative swabs each. Their parents were also negative, despite having reported the occurrence of mild typical symptoms, including ageusia and anosmia, in the previous weeks.

Chest X-ray showed mild retrocardiac consolidation in two cases, whereas in one, chest CT confirmed dorsal patchy interstitial and alveolar infiltrates \[[Figure 1](#F1){ref-type="fig"}\]. Three patients displayed moderate respiratory distress and arterial desaturation in the range of 90% requiring low-flow oxygen. None of the patients required escalation to either noninvasive or mechanical ventilation.

![(a) Chest X-ray, anteroposterior projection. (b) Chest computed tomography of the same patient showing interstitial and alveolar infiltrates](APC-13-230-g001){#F1}

Electrocardiogram (ECG) was not specific in three cases, apart from sinus tachycardia secondary to fever. In one patient, pericarditis-like changes were observed, whereas in two, QRS voltage reduction and fragmentation transiently developed \[[Figure 2](#F2){ref-type="fig"}\].\[[@ref3]\] Echocardiography revealed mild-to-severe left ventricular (LV) dysfunction associated with mild pericardial effusion in three patients, but all fully recovered in 48--72 h. The median lowest LV ejection fraction was 50% (25--60). The two patients with significant LV dysfunction needed admission in intensive care unit and inotropic support with milrinone (0.4--0.8 mcg/kg/min) in one case and milrinone plus adrenaline (0.05 mg/kg/min) in the other one. We have not seen any significant clinical sequelae, and all patients were transferred out of the intensive care unit to the pediatric ward for further observation. The median duration of the acute phase ranged between 3 and 5 days.

![(a and b) Electrocardiogram tracings of two patients with typical myocarditis. Arrows and circles indicate QRS fragmentation](APC-13-230-g002){#F2}

DISCUSSION {#sec1-4}
==========

Preliminary data from China and Spain suggest that the clinical impact of SARS-CoV2 infection in patients younger than 18 years is negligible in comparison with the general population. However, the true incidence of COVID-19 in pediatric patients is unknown due to the high prevalence of asymptomatic infections, atypical clinical presentation, and the low sensitivity of nasopharyngeal swab.\[[@ref2][@ref4]\] Instead, evidence of various degrees of myocardial injury is commonly observed among children with SARS-CoV2 infection. SARS-CoV2 is shown to be associated with a clinical syndrome like Kawasaki disease.\[[@ref5][@ref6][@ref7]\]

The cluster of symptoms and signs that we observed could have been grouped into two main, although overlapping, groups: one fulfilling criteria for Kawasaki disease, with or without coronary or myocardial involvement, and a second one presenting with isolated myocarditis \[[Table 1](#T1){ref-type="table"}\]. A typical common laboratory finding was a significant increase in leukocyte count and inflammatory markers. Two patients also had an exceptional increase of both triglyceride and ferritin levels, as described in macrophage activation syndrome. In its complete presentation, this condition is a serious complication of different rheumatology conditions.\[[@ref8]\]

The remaining two patients displayed a clinical course compatible with myocarditis. In both these patients, ECG was a sensitive tool in showing evolving changes characterized by ST changes and fragmentation of QRS. Despite a severe clinical presentation with markedly depressed LVEF, a rapid and complete recovery was observed. Remarkably, although COVID-19 infection was strongly suspected in all cases based on epidemiological and clinical grounds, only half the patients had a positive swab test. This is in line with preliminary reports suggesting a lower sensitivity of conventional virological investigations in children as compared with adults. It is worth noting that we are observing an unusual peak of Kawasaki-like syndromes and myocarditis in the pediatric population which is closely following the epidemiological peak of COVID-19 in our area. We might, therefore, speculate that this novel coronavirus could have acted as an immunological trigger after a few weeks from the initial infection that might have gone almost unrecognized in this population.\[[@ref9]\]

We also noted that unlike the "adult-type COVID-19," lung involvement may be unrecognized in the chest X-ray even in more severe clinical presentation in children, warranting a low threshold for proceeding with chest CT.\[[@ref4][@ref10]\] Furthermore, this initial cohort showed some unique humoral hallmarks of macrophage activation syndrome. This is a novel finding worth actively looking for, as this condition may carry a poor prognosis and need early aggressive treatment.
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